Sova Pharmaceuticals, is a biopharmaceutical company engaged in the discovery and development of small therapeutics for the treatment of inflammatory and neuropathic pain.
Sova Pharmaceuticals, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.sovapharma.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address11099 North Torrey Pines Road, Suite 290, CA, 92037La JollaUnited States
11099 North Torrey Pines Road, Suite 290, CA, 92037
La Jolla
United States
Contact Number+1 858-750-4700
+1 858-750-4700
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sova-pharmaceuticals-inc.” connections=”true” suffix=””]
The Companys Technology is based on modulation of cystathionine-?-lyase (CSE), a novel enzymatic target involved in the production of hydrogen sulfide(H2S), which imparts a multi-modal effect across various ion channels involved in nociception and signal transmission.
Avlon Ventures provided an Undisclosed funding to Sova pharmaceuticals for the development of therapeutics to treat central sleep apnea. Also, ResMed Inc., provided a undisclosed funding to Sova Pharmaceuticals.